AnaSpec Introduces HTS-Optimized EnzoLyte Caspase Assay Kits
Released on = September 12, 2006, 11:16 am
Press Release Author = Debra Thai
Industry = Biotech
Press Release Summary = Apoptosis, a programmed, cell-autonomous death process, plays important roles in a variety of physiological and pathological events (1).
Press Release Body = These range from normal fetal development to diseases, such as cancer (2), organ failure and neurodegenerative diseases. During apoptosis, caspases execute the disassembly of cellular components by proteolytic cleavage of a variety of substrates, such as poly-(ADP ribose) polymerase (3), DNA-dependent protein kinase (DNA-PK), topoisomerases, and protein kinase C delta (4). At least ten caspases have been discovered. Some of these caspases identify and cleave a specific peptide substrate, while others recognize the same peptide substrate (4).
AnaSpec's line of EnzoLyteT Caspase Assay Kits are optimized for high-throughput screening. HTS-optimized features include: one-step homogeneous assays, a convenient mix-and-read format, and highly sensitive fluorimetric components.
EnzoLyteT Homogeneous Caspase-3/7 Assay Kits - For detecting caspase 3/7 activity in cells and/or for screening caspase 3/7 inducers or inhibitors - Measures activity directly in 96- or 384-well microplate, bifunctional lysis buffer lyses cells as well as provides optimal buffer condition for caspase 3/7 activity
EnzoLyteT Homogeneous AFC Caspase-3/7 Assay Kit 500 assays in 96-well format Ex/Em(nm)
Web Site = http://http://www.anaspec.com/products/promotions.asp?col
Contact Details = 2149 O\'Toole Ave. San Jose, CA 95131 Tel: 800-452-5530 Fax: 408-452-5055 info@anaspec.com marketing@anaspec.com www.anaspec.com
Printer
Friendly Format
Back
to previous page...
Back
to home page...
Submit
your press releases...
|